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Abstract
Background/Aim. Surgical extraction of lower third mo-
lars is followed by mild or severe postoperative pain which
peaks at maximal intensity in the first 12 hours and has a
significant impact on a patient’s postoperative quality of life.
The use of long-acting local anaesthetics is a promising
strategy to improve postoperative analgesia. The aim of the
present study was to investigate analgesic parameters and
patient satisfaction after using 0.5% levobupivacaine
(Lbup), 0.5% bupivacaine (Bup) and 2% lidocaine with epi-
nephrine 1:80,000 (Lid + Epi) for an inferior alveolar nerve
block following lower third molar surgery. Methods. A to-
tal of 102 patients (ASA I) were divided into three groups,
each of which received either 3 mL of Lbup, Bup or Lid +
Epi. The intensity of postoperative analgesia was measured
using a verbal rating scale (VRS). The total amounts of res-
cue analgesics were recorded on the first and during seven
postoperative days. Patients satisfaction was noted using a
modified verbal scales. Results. A significantly higher level
of postoperative pain was recorded in Lid + Epi group
compared to Bup and Lbup groups. No significant differ-
ences were seen between Bup and Lbup, but a significant
reduction in the need for rescue analgesics was seen post-
operatively in both Lbup and Bup (50%) in comparison
with Lid + Epi (80%) in the first 24 hours. The same sig-
nificant trend in rescue analgesic consumption was recorded
for seven postoperative days. Patients’ overall satisfaction
was significantly lower for Lid + Epi (10%) than for Lbup
(56%) and Bup (52%). Conclusion. The use of a new and
long-acting local anaesthetic 0.5% levobupivacaine is clini-
cally relevant and effective for an inferior alveolar nerve
block and postoperative pain control after third molar sur-
gery. In our study Lbup and Bup controled postoperative
pain more efficiently after lower third molar surgery com-
pared to Lid + Epi.
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Apstrakt
Uvod/Cilj. Hirurško vaĀenje donjih impaktiranih umnjaka
praýeno je bolom umerenog do jakog intenziteta, sa maksi-
malnim intenzitetom tokom prvih 12 sati, koji ima znaÿajan
uticaj na kvalitet života pacijenata u postoperativnom perio-
du. Upotreba dugodelujuýih lokalnih anestetika predstavlja
obeýavajuýu strategiju za poboljšanje postoperativne analge-
zije. Cilj ove studije bio je da se ispitaju analgetiÿki parametri
i zadovoljstvo pacijenata postignutom analgezijom u posto-
perativnom periodu nakon primene 0,5% levobupivakaina
(Lbup), 0,5% bupivakaina (Bup) i 2% lidokaina sa epinefri-
nom (1: 80,000) (Lid + Epi) za sprovodnu anesteziju donjeg
alveolarnog nerva prilikom hirurškog vaĀenja donjih umnja-
ka. Metode. Ukupno 102 pacijenta (ASA I) bila su podelje-
na u tri grupe u zavisnosti od primljenog anestetika: 3 mL
Lbup, 3 mL Bup ili 3 mL Lid + Epi. Intenzitet postoperati-
vne analgezije registrovan je primenom verbalne rangirajuýe
skale (VRS). Zabeležena je ukupna koliÿina primenjenih
analgetika nakon prvog i sedmog postoperativnog dana.
Zadovoljstvo pacijenata ocenjivano je na osnovu modifiko-
vanih verbalnih skala. Rezultati. Znaÿajno jaÿi intenzitet
postoperativnog bola zabeležen je u grupi Lid + Epi, u po-
reĀenju sa grupama Lbup i Bup. Znaÿajno smanjenje potre-
be za analgeticima u postoperativnom periodu zabeleženo u
grupama Lbup i Bup (50%) u poreĀenju sa grupom Lid +
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Epi (80%) nakon 24 ÿasa. Znaÿajno smanjenje potrebe za
postoperativnim analgeticima u grupama Lbup i Bup zabe-
leženo je i nakon 7 dana. Potpuno zadovoljstvo pacijenata
postignutom analgezijom bilo je znaÿajno slabije u grupi Lid
+ Epi (10%) u poreĀenju sa grupama Lbup (56%) i Bup
(52%). Zakljuÿak. Upotreba novog dugodelujuýeg lokalnog
anestetika 0,5% levobupivakaina kliniÿki je relevantna i efi-
kasna za sprovodnu anesteziju donjeg alveolarnog nerva i
kontrolu postoperativnog bola nakon hirurškog vaĀenja do-
njih umnjaka. U našoj studiji Lbup i Bup bili su efikasniji u
kontroli postoperativnog bola nakon hirurškog vaĀenja do-
njih umnjaka u poreĀenju sa Lid + Epi.
Kljuÿne reÿi:
zub, ekstrakcija; umnjaci; bupivakain; lidokain;
anestezija, stomatološka; bol, postoperativni; upitnici.
Introduction
Surgical extraction of impacted lower third molars is
considered the standard clinical model in pain studies, due to
the evidence of moderate to severe postoperative pain which
leads to increased pain perception and causes patient dissatis-
faction 1. Postoperative pain levels have also been found to
have a significant impact on the quality of life after third
molar surgery 2. Thus, the successful control of postoperative
pain is a prerequisite for general patient compliance with
oral-surgical procedures.
The standard protocol for pain control in third molar sur-
gery involves the preoperative administration of local anaes-
thetics along with the intermediate action and postoperative
use of analgesics. However, intermediate anaesthetics are not
analgesics during the periods of the most intensive postopera-
tive pain experienced (6–8 hours), leading to the faster onset of
postoperative pain and increased consumption of postoperative
analgesics. Furthermore, any failure in postoperative pain
control may contribute to the develoment of central sensitisa-
tion 3, a state of hyperexcitability in the central nervous system
that may even persist for 30 days after third molar surgery 4. It
has been demonstrated that the use of long-acting local anaes-
thetics for the prolonged blockage of nociceptive impulses
arising from the site of surgery may be a promising strategy
for improving postoperative analgesia 5.
Bupivacaine (Bup) was a widely used, long-acting local
anaesthetic which provided relatively fast relief and prolonged
block anaesthesia and delayed onset of postoperative pain 6.
However, due to clinical reports citing life-threatening cardiac
issues and its neurotoxic effects, it became evident that bu-
pivacaine had a narrow safety margin, especially after an un-
wanted intravascular injection 7–10. On the other hand, levobu-
pivacaine (Lbup) is a long-acting local anaesthetic with
chemical and physical properties identical to bupivacaine but
with lower toxicity seen in in vitro, in vivo and human volun-
teer studies 11–14. Comparative clinical studies evaluating equ-
vivalent doses of 0.5% Lbup and Bup for peripheral nerve
blocks have suggested that clinical parameters were similar or
even better with 0.5% levobupivacaine 15–18. In dentistry, one
human volunteer study compared the anaesthetic properties of
0.5% Bup and 0.5% Lbup, both associated with epinephrine (1
: 200,000), and found no significant differences between the
two anaesthetics in achieving onset time and duration of soft
tissue and pulpal anaesthesia for an inferior alveolar nerve
block 19.
The aim of the study was to investigate analgesic pa-
rameters and patient satisfaction after using 0.5% Lbup,
0.5% Bup and 2% lidocaine with epinephrine (1 : 80,000)
(Lid + Epi) for inferior alveolar nerve block in patients un-
dergoing lower third molar surgery.
Methods
The study was performed at the Clinic for Oral Surgery,
Faculty of Dental Medicine, University of Belgrade, with in-
stitutional approval from the Ethical Commitee (No. 36/32).
The patients were classified as having physical status 1 ac-
cording to the American Society of Anesthesiologists (ASA)
classification. Exclusion criteria were: age under 18, preg-
nant women, nursing mothers, smokers, patients with any
signs of acute or chronic pain in the orofacial region and any
antibiotic or analgesic intake within seven days preopera-
tively. Specific inclusion criteria were patients with fully im-
pacted lower third molars (more than two-thirds of the crown
covered with alveolar bone, confirmed by radiographic
analysis) with no signs of acute pericoronitis or any acute in-
fection. The patients were studied using a double-blind, con-
trolled design and were randomly allocated to three groups
receiving either 3 mL of 2% lidocaine with 1 : 80,000 epi-
nephrine (Lidokain-Adrenalin 2%®, Galenika, Serbia) – Lid
+ Epi; 3 mL of 0.5% bupivacaine (Marcaine®, AstraZeneca,
United Kingdom) – Bup; 3 mL of 0.5% levobupivacaine
(Chirocaine®, Abbott, USA) – Lbup.
Random assignments were carried out by an independ-
ent investigator according to a computer-generated randomi-
sation list with sealed numbered envelopes. The patients re-
ceived a total of 3.0 mL of local anaesthetic in the following
manner: 2.0 mL for the inferior alveolar nerve block, 0.5 mL
for the lingual nerve block and 0.5 mL for the buccal nerve
block. No premedication was given. Since 0.5% Bup and
0.5% Lbup were not available in dental cartridges, they were
drawn from 10 and 20 mL vials by a clinical pharmacist not
involved in the study. The same surgeon performed all the
blocks. The time from the application of anaesthetic to the
beginning of surgery was limited to 15 minutes. If additional
anaesthesia was given due to a prolonged onset time or the
presence of intolerable intraoperative pain, anaesthesia was
considered unsuccessful and the patients were excluded from
the study. Additional anaesthesia was achieved by adminis-
tering 2% lidocaine with epinephrine (1 : 80,000) (Lidokain-
Adrenalin 2%®, Galenika, Serbia). At the end of surgery, the
patients were given a study questionnaire with detailed in-
structions for collecting the protocol parameters of postop-
erative analgesia. Regular postoperative follow-ups were
scheduled for the first and seventh days after the surgery.
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The questionnaires were returned back seven days after the
surgery, when the patients’ sutures were removed.
The postoperative analgesia protocol consisted of clear
instructions for analgesic consumption (ibuprofen 400 mg
per os, Brufen®, Galenika, Serbia) in the case of pain experi-
enced at the surgical site of moderate to severe intenstity,
identified at the level of  4 according to the Verbal Rating
Scale (VRS). The VRS consists of a list of six-point scale
phrases (0 – no pain; 1 – just notable pain; 2 – weak pain; 3 –
moderate pain; 4 – severe pain; 5 – excrutiating pain) which
represent the levels of pain intensity. The patients were in-
structed to grade pain intensity at fixed time points 2, 4, 6, 8,
12, 24 and 48 hours postoperativelly. Also, the patients were
instructed to record the total amount of analgesics taken in
the first 24 hours and over seven days postoperatively.
In order to evaluate the patients satisfaction with the
administered analgesia and the overall satisfaction with the
treatment, a five-point verbal scale was used: 1 – poor, 2 –
fair; 3 – good; 4 – very good; 5 – excellent. The patients
evaluated the duration of anaesthesia using a three-point ver-
bal scale: 1 – not enough; 2 – enough; 3 – too long.
Statistical analysis was performed using the statistical
software SPSS, version 18.0. The results were presented as the
mean ± standard deviation (SD), while Ȥ2 test was performed
to determine the differences in gender and the patient’s satis-
faction with the treatment and analgesia. Age, weight, the du-
ration of operative procedure and analgesic uptake were com-
pared using parametric one-way ANOVA with post-hoc Tu-
key test. When normal data distribution was not present, non-
parametric Kruskal-Wallis and Mann-Whitney tests were
used. The difference of p < 0.05 was considered significant.
The group size was estimated based on a pilot study. In order
for the study to have 80% power, with type I errors of 0.05 and
assumed differences detected at 40%, the total sample size re-
quired was 82 patients. The sample size was calculated using
the statistical program G*Power 3.1. (Heinrich-Heine-
University, Dusseldorf, Germany).
Results
The flow diagram demonstrates randomisation of patients
enrolled in the study (Figure 1). Initially, 125 patients were
examined but 102 met the enrollement criteria. The patients
were randomised into three groups of 34 each and received
either levobupivacaine, bupivacaine or lidocaine with epineph-
rine. Due to discontinued intervention and the lost of follow-
ups, 3, 7, and 7 patients from Lid + Epi, Bup and Lbup groups,
respectivelly, were excluded from the study. The subjects'
demographic and clinical data are summarised in Table 1.
There were statistically significant differences in post-
operative pain intensity among the three investigated groups
over 4 to 48 hours. Significantly higher levels of postopera-
tive pain were recorded in the Lid + Epi compared to the Bup
and Lbup groups at each time point. The patients in the Bup
and Lbup groups experienced similar postoperative pain in-
tensities except during the sixth hour, when pain levels were
significantly higher in the Bup cohort (Figure 2). In addition,
significantly more patients experienced moderate to severe
Assessed for eligibility (n = 125)
Enrolment
Excluded (n = 23)
Not meeting inclusion criteria (n = 20)
Refused to participate (n = 3)
Randomized
(n = 102)
 Allocation
Allocated to intervention
group  Lid + Epi (n = 34)
Received allocated
intervention (n = 34)
Allocated to intervention
group LBUP (n = 34)
Received allocated
intervention (n = 34)
Lost to follow-up (n = 1)
Discontinued intervention (n = 2)
Lost to follow-up (n = 4)
Discontinued intervention (n = 3)
 Follow-Up
  Analysis
Lost to follow-up (n = 3)
Discontinued intervention (n = 4)
Analyzed 2% Lid + Epi
 (n = 31)
Analyzed 0.5% BUP
 (n = 27)
Analyzed 0.5% LBUP
 (n = 27)
 (n=0)
Allocated to intervention
group  BUP (n = 34)
Received allocated
intervention (n = 34)
Fig. 1 – Flow diagram of randomization either 2% lidocaine with epinephrine (1 : 100,000) (Lid + Epi), 0.5% bupivacaine
(BUP) or 0.5% levobupivacaine (LBUP) for lower third molar surgery.
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Fig. 2 – Pain intensity according to the verbal rating scale
(VRS) after lower third molar surgery. Lid + Epi: 2% lidocaine
with 1 : 100,000 epinephrine; Bup: 0.5%  bupivacaine; Lbup:
0.5% levobupivacaine; VRS: verbal rating scale; *p < 0.05: Lid
+ Epi vs. 0.5% Bup, Lid + Epi vs. Lbup  (Kruskall-Wallis test,
Mann-Whitney U test); **p < 0.05: Bup vs. LBUP (Kruskall-
Wallis test, Mann-Whitney U test).
postoperative pain (VRS  4) in the Lid + Epi group for all
the measured time intervals (Table 2). A significant reduc-
tion in the need for rescue medication in the first 24 hours
postoperatively was seen in both the Lbup and Bup groups
(50% of patients required pain medication) as compared to
the Lid + Epi patient sample where 80% of patients required
pain medication (Table 3). A total analgesic consumption,
measured after the first 24 hours till the seventh day follow-
ing the surgical procedure was significantly less in the Lbup
and Bup groups compared to the Lid + Epi group (Table 3).
Regarding the patient’s satisfaction with the achieved
postoperative analgesia, 60% (16/27) and 63% (17/27) of
patients in the groups Bup and Lbup, respectively, declared
achieved analgesia as excellent, compared to 10% (3/31) in
the Lid + Epi group. This difference was statistically signifi-
cant (Figure 3). The five-point verbal scale measurement
showed that the mean score for the achieved analgesia was
3.00 ± 1.05, 4.52 ± 0.89 and 4.41 ± 0.91 in the Lid + Epi,
Bup and Lbup group, respectively (p < 0.05; Kruskal-Wallis
rank test), with a significant decrease in the Lid + Epi group
compared to both the Lbup and Bup groups [(p < 0.05,
Mann-Whitney test); (data on patient’s satisfaction with the
Table 2
Percentage of patients experiencing moderate-to-severe postoperative pain according to the verbal rating scale (VRS  4)
over 48-hour period after 2% lidocaine with 1 : 100,000 epinephrine (Lid + Epi), 0.5%  bupivacaine (Bup) and 0.5%
levobupivacaine (Lbup)
Groups 2h 4h* 6h* 8h* 12h* 24h* 48h*
Lid + Epi 6 16 48 42 35 26 16
Bup 0 4 11 15 4 4 4
Lbup 0 4 7 11 7 4 6
   *p < 0,05, Ȥ2 test.
Table 3
Postoperative analgesic consumption after anesthesia with 2% lidocaine with 1:100,000 epinephrine (Lid+ Epi), 0.5%
bupivacaine (Bup) and 0.5% levobupivacaine (Lbup)
Parameters Lid + Epi Bup Lbup
N1 25/30* 14/27 14/27
N2 29/30 20/30 21/30
Pain medcation 24 h (mg), ʉ ± SD 1280 ± 450** 630 ± 243 543 ± 277
Pain medication 7 days (mg), ʉ ± SD 3430 ± 1633** 1788 ± 832 1640 ± 759
N1 –  number of patients requiring pain medication during 24 hours; N2 – number of patients requiring pain medication during 7 days;
*p < 0.05 (Chi-square test), **p < 0.05 – Lid + Epi vs. Bup; Lid+Epi vs Lbup (One-way ANOVA, post hoc Tukey test).
Table 1
Patient's demographic and clinical data
Parameters Lid + Epi Bup Lbup
Number of patients 30 27 27
Female/Male, n 19/11 18/9 19/8
Age (years), ʉ ± SD 23.6 ± 4.0 23,9 ± 3,5 24,4 ± 5,1
Weight (kg), ʉ ± SD 67 ± 13 65 ± 12 68 ± 15
Impacted third molars, n 30 27 27
Duration of operation
(min), ʉ ± SD
14.3 ± 4.2 13.3 ± 3.9 15.5 ± 4.5
Section of crown and roots
(yes/no), n
20/10 19/8 18/9
Bone removal, n
mesial 6 7 5
distal 16 18 19
oclusal 3 2 2
buccal 0 1 0
lingual
Lid + Epi : 2% lidocaine with 1 : 100,000 epinephrine; Bup : 0.5% bupivacaine; Lbup : 0.5% levobupivacaine.
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achieved postoperative analgesia are not presented)]. Re-
garding the patients’ evaluation of the duration of anaesthe-
sia, significantly more patients in the Lbup and Bup groups
(40% in both groups) found local anaesthesia lasted too long
in comparison to the Lid + Epi group  (13%) (Figure 4). The
patients’ overall satisfaction was significantly lower in the
Lid + Epi group (10% of patients declared an excellent level)
than in the Lbup (56% excellent) and Bup (52% excellent)
(Figure 5). The mean scores for overall satisfaction with the
treatment quality were 3.22 ± 0.65, 4.26 ± 0.75 and 4.48 ±
0.82 for the Lid + Epi, Bup and Lbup groups, respectively (p
< 0.05; Kruskal-Wallis rank test), with a significant decrease
in the Lid + Epi group compared to the other two groups [(p
< 0.05, Mann-Whitney test); (data for overall satisfaction are
not presented)].
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Fig. 4 – Subject’s satisfaction with the duration of anesthesia.
Lid  + Epi: 2% lidocaine with 1 : 100,000 epinephrine; Bup:
0.5% bupivacaine; Lbup: 0.5% levobupivacaine; *p < 0.05,
Ȥ2 test.
Discussion
The present, randomised, prospective, double-blind
study demonstrated that 0.5% levobupivacaine, as a new
long-acting local anaesthetic for use in oral surgery, was ef-
fective in achieving postoperative analgesia after lower third
molar surgery, as it has been well known for 0.5% bupiva-
caine 6, 20. On the other hand, intermediate anaesthetic, such
as 2% lidocaine with epinephrine, did not show clinically
relevant postoperative analgesic effects, because its duration
of action duration did not cover the early postoperative pe-
riod which is determined by a significant intensity of postop-
erative pain. Since postoperative pain after third molar sur-
gery reaches its maximal intensity in the first 12 hours 21, and
due to the high frequency of third molar surgery, it would be
of great importance to use a local anaesthetic that provides
prolonged analgesia and decreases patient discomfort. Fur-
thermore, the reduction of postoperative pain improves qual-
ity of life, reduces morbidity and allows for the rapid return
to daily activities 2.
Previously published results on the analgesic effect of
levobupivacaine in third molar surgery may not be compared
easily to our research, due to different concentrations of le-
vobupivacaine used (0.75%) 22, 23, whilst in the study of Rood
et al. 22, third molars were extracted under general anaesthe-
sia and for postoperative pain relief either 0.75% levobu-
pivacaine, 2% lignocerine with adrenaline 1 : 80,000, or pla-
cebo. However, at clinical concentrations of 0.5% and
0.75%, levobupivacaine does produce long-lasting block an-
aesthesia 22, 23. This long-lasting effect of both levobupiva-
caine and bupivacaine can be attributed to the drugs’ phar-
macokinetic properties. Specifically, the protein-binding co-
efficient of lidocaine is 64%, which is much lower than the
96% of bupivacaine and levobupivacainen 24. The high pro-
tein-binding coefficient of bupivacaine and levobupivacaine
allows local anaesthetics’ molecules to bond to tissue pro-
teins and ensure increased concentrations of anaesthetic
molecules at the site of injection which are responsible for
prolonging the duration of anaesthesia 25, 26.
It is well-documented that surgical trauma and subse-
quent inflammation induce the sensitivity of peripheral noci-
ceptors (primary hyperalgesia), a notion which has been
clinically observed as increased postoperative pain emanat-
ing from the site of surgery 27. Inadequate and short-lasting
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Fig. 3 – Subject’s satisfaction with the achieved analgesia.
Lid + Epi: 2% lidocaine with 1 : 100,000 epinephrine: Bup :
0.5% bupivacaine; Lbup: 0.5% levobupivacaine; *p < 0.05,
Ȥ2 test.
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Fig 5 – Overall satisfaction with quality of the treatment.
Lid + Epi: 2% lidocaine with 1 : 100,000 epinephrine: Bup :
0.5% bupivacaine; Lbup : 0.5% levobupivacaine;
*p < 0.05, Ȥ2 test.
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nerve blocks may cause prolonged and enhanced postopera-
tive pain, leading to central neural sensitisation 27, 28, which
results in pain hypersensitivity beyond the area of surgery
(secondary hyperalgesia) and the presence of pain after
stimulus (allodynia)3. Juhl et al. 4, 28 showed that third molar
surgery was followed by long-lasting mechanical, thermal
and electrical sensitisation 30 days after intervention, even in
the absence of spontaneous pain and consumption of postop-
erative analgesics. These findings suggest that anaesthetic
blocks should last until inputs from peripheral surgical sites
drop below the level that can maintain central sensitisation,
especially in the hours immediately following lower third
molar extraction. It is also recommended that long-acting lo-
cal anaesthetics should be a part of the pre-emptive analgesia
protocol, because it starts before surgery (anaesthetic injec-
tion before surgery) and lasts a good deal of time after sur-
gery, in order to prevent postoperative pain and to reduce
administration of postoperative analgesic therapy 29, 30. Our
results show that the analgesic efficacy of long-acting local
anaesthetics is seen up to 48 hours postoperatively, long after
local anaesthetic action has finished. In addition, the total
amount of rescue analgesics is significantly lower with bu-
pivacaine and levobupivacaine treatment over a seven-day
period. These results could presents the indirect proof of the
suppression of central sensitisation. Conversely, the use of
lidocaine with epinephrine which is an intermediate local an-
aesthetic, does not provide sufficient blockage of postopera-
tive neural hyperexcitability.
Regarding the patient’s satisfaction with the overall
treatment, significantly higher number of patients marked
bupivacaine and levobupivacaine higher than lidocaine with
epinephrine. It could be postulated that the overall patient’s
satisfaction is in strong correlation with satisfaction with the
achieved analgesia, while prolonged analgesia seemed to fa-
vour the patients’ choice of a better anaesthetic. Moreover,
the quality of life after oral surgical interventions can have a
major impact on a patient’s future perception of pain and
preoperative anxiety 31.
Conclusion
In our study, 0.5% levobupivacaine and 0.5% bupiva-
caine provided more pronounced postoperative analgesic ef-
fects in comparison to 2% lidocaine with epinephrine
(1:80,000), due to the reduced levels of postoperative pain
and the need for postoperative analgesic consumption. In ad-
dition, 0.5% levobupivacaine provided an analgesic effect
similar to 0.5% bupivacaine after third molar surgery.
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